Lengthy-performing properties and potential related dangers with SUNLENCA: Residual concentrations of SUNLENCA may continue to be while in the systemic circulation of individuals for as much as 12 months or for a longer time. SUNLENCA may possibly boost exposure, and likely hazard of adverse reactions, to prescription drugs mostly metabolized by CY